ADMA BIOLOGICS, INC.

ADMA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $2.5B · 647 employees
396
SEC Filings
$9.14
Close 2026-09-14
647
Employees

Business Summary

ADMA Biologics is a U.S.-based commercial biopharmaceutical company that manufactures, markets, and develops specialty biologics for immunodeficient patients. Its FDA-approved products include ASCENIV and BIVIGAM (IVIG products for Primary Immunodeficiency) and Nabi-HB (Hepatitis B Immune Globulin). The company operates a plasma fractionation facility in Boca Raton, FL, and ten plasma collection centers through its ADMA BioCenters subsidiary, supporting both internal manufacturing and third-party plasma sales.

Latest Stock Quote

ADMA 2026-09-14 $9.14 O:$9.34 H:$9.375 L:$9.065 Vol:3.1M VWAP:$9.1501
origin leaf: null

Next Earnings

expected 2026-11-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001140361-26-006815EDGAR90K words
2025-03-182024-12-310001140361-25-009257EDGAR90K words
2024-02-282023-12-310001140361-24-010147EDGAR85K words
2023-03-232022-12-310001140361-23-013467EDGAR—
2022-03-242021-12-310001140361-22-011030EDGAR—
2021-03-252020-12-310001193805-21-000411EDGAR—
2020-03-132019-12-310001193805-20-000348EDGAR—
2019-03-132018-12-310001193805-19-000281EDGAR—
2018-03-292017-12-310001193805-18-000470EDGAR—
2017-02-242016-12-310001193805-17-000330EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001140361-26-031445EDGAR55K words
2025-11-052025-09-300001140361-25-040578EDGAR50K words
2025-08-062025-06-300001140361-25-029177EDGAR51K words
2025-05-072025-03-310001140361-25-017747EDGAR44K words
2024-11-072024-09-300001140361-24-045693EDGAR52K words
2024-08-082024-06-300001140361-24-036432EDGAR51K words
2024-05-092024-03-310001140361-24-025226EDGAR46K words
2023-11-082023-09-300001140361-23-052109EDGAR53K words
2023-08-092023-06-300001140361-23-038843EDGAR52K words
2023-05-102023-03-310001140361-23-023920EDGAR49K words
2022-11-092022-09-300001140361-22-040738EDGAR—
2022-08-102022-06-300001140361-22-029116EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050001140361-26-031423EDGAR7K words
2026-03-270001140361-26-011569EDGAR3K words
2026-03-020001140361-26-007230EDGAR1K words
2026-02-250001140361-26-006781EDGAR6K words
2026-01-120001140361-26-000906EDGAR4K words
2025-11-050001140361-25-040539EDGAR5K words
2025-08-060001140361-25-029143EDGAR5K words
2025-06-040001140361-25-021440EDGAR1K words
2025-05-070001140361-25-017704EDGAR5K words
2025-04-280001140361-25-015881EDGAR1K words

396 total filings indexed. 364 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE ABPO — Abpro Holdings, Inc.

Tags

primary-immunodeficiency-disease-(pidd)-treatment hepatitis-b-post-exposure-prophylaxis plasma-collection-and-third-party-plasma-supply contract-manufacturing-and-laboratory-services immunocompromised-patient-specialty-biologics fda-biologics-license-application-(bla) prior-approval-supplement-(pas) healthcare-common-procedure-coding-system-(hcpcs)-j-code-(j1554) korean-ministry-of-food-and-drug-safety-(mfds)-approval fda-plasma-collection-center-licensing commissioners-national-priority-voucher-(cnpv)

Company Identity

CIK0001368514
TickerADMA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersBoca Raton, Florida
Websitehttps://www.admabiologics.com
Listed2013-10-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 4cc705d13c9e5e35e40d1994a9bbc41edc7b751c56431b9b4db2b896a9a63109
parent: 9722ae22c880f9499816522485b36fe472395156da25df676fef41bce111b030
content hash: a7f0d146bcdb8a0fa0601d9e630414a20f9fd3a399a8b3e59a5e13af15bb9226
signed: 2026-09-28T19:00:07.564Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ADMA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ADMA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ADMA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.